Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › bivalirudin

bivalirudin

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of bivalirudin

7 trials tracked of bivalirudin: 6 in phase 3 or 4 and 3 with published results. The most-cited published study has 124 citations.

7Trials tracked
6Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 3 Phase 3 3 Other / NA 1
  1. Phase 3 Open-label, Randomized Trial in Participants Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH Completed · 124 cited
  2. Phase 3 Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Completed · 56 cited
  3. Phase 4 Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO Completed · 14 cited
  4. Phase 4 Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography Completed
  5. Phase 4 How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention Completed
  6. Phase 3 European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial Completed
Show 1 more trials
  1. N/A Simplified Anti-Thrombotic Therapy for FFR Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Bivalirudin reduces in-hospital major bleeding and 30-day mortality in patients with acute coronary syndrome
Cardiology Meta-analysis
Bivalirudin reduces in-hospital major bleeding and 30-day mortality in patients with acute coronary syndrome Bivalirudin shows lower bleeding risks than heparin for heart patients
This meta-analysis of 584,249 patients with acute coronary syndrome undergoing percutaneous coronary intervention found that bivalirudin sig…
A large analysis suggests bivalirudin may reduce major bleeding and mortality in patients undergoing procedures for acute coronary syndrome.
NEJM Sep 27, 2026
Shorter heparin-to-bivalirudin bridging times (≤30 min) reduce hospitalization in acute coronary syndrome patients undergoing PCI
Cardiology Cohort
Shorter heparin-to-bivalirudin bridging times (≤30 min) reduce hospitalization in acute coronary syndrome patients undergoing PCI The Clock Is Ticking When You Switch Blood Thinners During Heart Surgery
This retrospective cohort study evaluated 197 patients with acute coronary syndrome undergoing percutaneous coronary intervention.
A simple timing tweak in how two common blood thinners are switched during heart procedures may cut the odds of landing back in the hospital…
Frontiers Apr 14, 2026